, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Proteomic consequences of a single gene mutation in a colorectal cancer model. Halvey PJ, Zhang B, Coffey RJ, Liebler DC, Slebos RJ (2012) J Proteome Res 11(2): 1184-95
    › Primary publication · 22103262 (PubMed) · PMC3271737 (PubMed Central)
  2. Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling. Myers MV, Manning HC, Coffey RJ, Liebler DC (2012) Mol Cell Proteomics 11(2): M111.015222
    › Primary publication · 22147731 (PubMed) · PMC3277773 (PubMed Central)
  3. Pierre Ménétrier and his disease. Coffey RJ, Tanksley J (2012) Trans Am Clin Climatol Assoc : 126-33; discussion 133-4
    › Primary publication · 23303980 (PubMed) · PMC3540591 (PubMed Central)
  4. Myofibroblast keratinocyte growth factor reduces tight junctional integrity and increases claudin-2 levels in polarized Caco-2 cells. Kim TI, Poulin EJ, Blask E, Bukhalid R, Whitehead RH, Franklin JL, Coffey RJ (2012) Growth Factors 30(5): 320-32
    › Primary publication · 22946653 (PubMed) · PMC3594790 (PubMed Central)
  5. Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature. Nam KT, O'Neal R, Lee YS, Lee YC, Coffey RJ, Goldenring JR (2012) Lab Invest 92(6): 883-95
    › Primary publication · 22411066 (PubMed) · PMC3584162 (PubMed Central)
  6. Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions. Shifrin DA, McConnell RE, Nambiar R, Higginbotham JN, Coffey RJ, Tyska MJ (2012) Curr Biol 22(7): 627-31
    › Primary publication · 22386311 (PubMed) · PMC3326206 (PubMed Central)
  7. [18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease. McKinley ET, Smith RA, Tanksley JP, Washington MK, Walker R, Coffey RJ, Manning HC (2012) Ann Nucl Med 26(9): 757-63
    › Primary publication · 22821337 (PubMed) · PMC3543701 (PubMed Central)
  8. Resistance to EGFR-targeted therapy: a family affair. Vlacich G, Coffey RJ (2011) Cancer Cell 20(4): 423-5
    › Primary publication · 22014569 (PubMed) · PMC3616495 (PubMed Central)
  9. Naked1 antagonizes Wnt signaling by preventing nuclear accumulation of β-catenin. Van Raay TJ, Fortino NJ, Miller BW, Ma H, Lau G, Li C, Franklin JL, Attisano L, Solnica-Krezel L, Coffey RJ (2011) PLoS One 6(4): e18650
    › Primary publication · 21490931 (PubMed) · PMC3072412 (PubMed Central)
  10. Identification of a novel mono-leucine basolateral sorting motif within the cytoplasmic domain of amphiregulin. Gephart JD, Singh B, Higginbotham JN, Franklin JL, Gonzalez A, Fölsch H, Coffey RJ (2011) Traffic 12(12): 1793-804
    › Primary publication · 21917092 (PubMed) · PMC3886124 (PubMed Central)